Deciding when to stop: Towards evidence-based deprescribing of drugs in older populations

Evidence-Based Medicine

Volumn 18, Issue 4, 2013, Pages 121-124

  Scott, Ian A ^a   Gray, Leonard C ^a   Martin, Jennifer H ^a   Pillans, Peter I ^b   Mitchell, Charles A ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b PRINCESS ALEXANDRA HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIANGINA PECTORIS AGENT; ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; ANTIPARKINSON AGENT; BACLOFEN; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISPHOSPHONIC ACID DERIVATIVE; CARDIOVASCULAR AGENT; CENTRAL NERVOUS SYSTEM AGENTS; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; NARCOTIC ANALGESIC AGENT; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL ANTIDIABETIC AGENT; PRESCRIPTION DRUG; PSYCHOTROPIC AGENT;

ABDOMINAL CRAMP; ACUTE CORONARY SYNDROME; AGING; AGITATION; AKATHISIA; ALGORITHM; ANGER; ANGINA PECTORIS; ANOREXIA; ANXIETY; ARTHRITIS; CARDIOVASCULAR DISEASE; CHILL; COMMON COLD; COMORBIDITY; CONFUSION; DELIRIUM; DEMENTIA; DEPRESSION; DIABETES MELLITUS; DIAPHORESIS; DIARRHEA; DIZZINESS; DRUG EFFICACY; DRUG INDICATION; DRUG MISUSE; DRUG WITHDRAWAL; DYSKINESIA; EVIDENCE BASED MEDICINE; FALLING; FRAGILITY FRACTURE; FRAIL ELDERLY; GASTROINTESTINAL DISEASE; GOUT; GROUPS BY AGE; HALLUCINATION; HEADACHE; HEALTH CARE SYSTEM; HEART FAILURE; HEART PALPITATION; HIGH RISK PATIENT; HUMAN; HYPERTENSION; HYPOTENSION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INAPPROPRIATE PRESCRIBING; INFLAMMATION; INSOMNIA; IRRITABILITY; LETHARGY; LIFE EXPECTANCY; LUNG EMBOLISM; MALAISE; MANIA; MEDICATION THERAPY MANAGEMENT; METASTASIS; MORTALITY; MUSCLE HYPERTONIA; MYALGIA; NAUSEA; NIGHTMARE; PARANOIA; PARKINSON DISEASE; PATIENT COMPLIANCE; PATIENT MONITORING; POLYPHARMACY; PREVENTIVE MEDICINE; PSYCHOSIS; REBOUND; RESTLESSNESS; REVIEW; RIGIDITY; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SEIZURE; SIDE EFFECT; SYSTEMATIC REVIEW (TOPIC); TACHYCARDIA; TREATMENT PLANNING; TREATMENT REFUSAL; TREMOR; VOMITING; WEAKNESS; WEANING;

CLINICAL PHARMACOLOGY; GERIATRIC MEDICINE;

AGED; DRUG PRESCRIPTIONS; EVIDENCE-BASED MEDICINE; HUMANS; INAPPROPRIATE PRESCRIBING; POLYPHARMACY;

EID: 84883746937     PISSN: 13565524     EISSN: 14736810     Source Type: Journal    
DOI: 10.1136/eb-2012-100930     Document Type: Review

References (28)

1. Kalisch LM, Caughey GE, Barratt JD, et al. Prevalence of preventable medication-related hospitalizations in Australia: an opportunity to reduce harm. Int J Qual Health Care 2012;24:239-49.
2. Kongkaew C, Noyce PR, Ashcroft DM. Hospital admissions associated with adverse drug reactions: a systematic review of prospective observational studies. Ann Pharmacother 2008;42:1017-25.
3. Doucet J, Jego A, Noel D, et al. Preventable and non-preventable risk factors for adverse drug events related to hospital admissions in the elderly. A prospective study. Clin Drug Invest 2002;22:385-92. (Pubitemid 34634279)
4. Chan M, Nicklason F, Vial JH. Adverse drug events as a cause of hospital admission in the elderly. Int Med J 2001;31:199-205. (Pubitemid 32592646)
5. Hanlon JT, Schmader KE, Koronkowski MJ, et al. Adverse drug events in high risk older outpatients. J Am Geriatr Soc 1997;45:945-8. (Pubitemid 27330124)
6. Buajordet I, Ebbesen J, Erikssen J, et al. Fatal adverse drug events: the paradox of drug treatment. J Intern Med 2001;250:327-41. (Pubitemid 32955618)
7. Hajjar ER, Hanlon JT, Sloane RJ, et al. Unnecessary drug use in frail older people at hospital discharge. J Am Geriatr Soc 2005;53:1518-23. (Pubitemid 41602441)
8. Mangin D, Heath I, Jamoulle M. Beyond diagnosis: rising to the multimorbidity challenge. BMJ 2012;344:e3526.
9. Scott IA, Martin JH, Gray LA, et al. Minimising inappropriate medication use in older populations-a 10 step conceptual framework. Am J Med 2012;125:529-37.
10. Scott IA, Martin JH, Gray LA, et al. Effects of a drug minimisation guide on prescribing intentions in elderly persons with polypharmacy. Drugs Ageing 2012;29:659-67.
11. Goldberg RM, Mabee J, Chan L, et al. Drug-drug and drug-disease interactions in the emergency department: analysis of a high risk population. Am J Emerg Med 1996;14:447-50. (Pubitemid 26272242)
12. Owen A, Cox S. Diagnosis of heart failure in elderly patients in primary care. Eur J Heart Fail 2001;3:79-81. (Pubitemid 32127113)
13. Meara J, Bhowmick BK, Hobson P. Accuracy of diagnosis in patients with presumed Parkinson's disease. Age Ageing 1999;28:99-102. (Pubitemid 29161211)
14. The American Geriatrics Society 2012 Beers Criteria Update Expert Panel. American Geriatrics Society updated criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc 2012;60:616-31.
15. Gallagher P, Ryan C, Byrne S, et al. STOPP (Screening Tool of Older Persons' Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. Int J Clin Pharmacol Ther 2008;46:72-83. (Pubitemid 351233792)
16. Fried TR, Tinetti ME, Towle V, et al. Effects of bene fits and harms on older persons' willingness to take medication for primary cardiovascular prevention. Arch Intern Med 2011;171:923-8.
17. Al-Rashed SA, Wright DJ, Roebuck N, et al. The value of inpatient pharmaceutical counselling to elderly patients prior to discharge. Br J Clin Pharmacol 2002;54:657-64. (Pubitemid 36002595)
18. Garfinkel D, Zur-Gil S, Ben-Israel J. The war against polypharmacy: a new cost-effective geriatric-palliative approach for improving drug therapy in disabled elderly people. Isr Med Assoc J 2007;9:430-4.
19. Garfinkel D, Mangin D. Feasibility study of a systematic approach for discontinuation of multiple medications in older adults: addressing polypharmacy. Arch Intern Med 2010;170:1648-54.
20. Starner CI, Norman SA, Reynolds RG, et al. Effect of a retrospective drug utilisation review on potentially inappropriate prescribing in the elderly. Am J Geriatr Pharmacother 2009;7:11-19.
21. Graves T, Hanlon JT, Schmader KE, et al. Adverse events after discontinuing medications in elderly outpatients. Arch Intern Med 1997;157:2205-10. (Pubitemid 27451146)
22. Lindström K, Ekedahl A, Carlsten A, et al. Can selective serotonin inhibitor drugs in elderly patients in nursing homes be reduced? Scand J Prim Health Care 2007;25:3-8.
23. Gallagher PF, O'Connor MN, O'Mahony D. Prevention of potentially inappropriate prescribing for elderly patients: a randomised controlled trial using STOPP/START criteria. Clin Pharmacol Ther 2011;89:845-54.
24. Iyer S, Naganathan V, McLachlan AJ, et al. Medication withdrawal trials in people aged 65 years and older: a systematic review. Drugs Aging 2008;25:1021-31.
25. Hill KD, Wee R. Psychotropic drug-induced falls in older people. A review of interventions aimed at reducing the problem. Drugs Aging 2012;29:15-30.
26. Gnjidic D, Le Couteur DG, Kouladjian L, et al. Deprescribing trials: methods to reduce polypharmacy and the impact on prescribing and clinical outcomes. Clin Geriatr Med 2012;28:237-53.
27. Kaur S, Mitchell G, Vitetta L, et al. Interventions that can reduce inappropriate prescribing in the elderly: a systematic review. Drugs Aging 2009;26:1013-28.
28. Ostini R, Jackson C, Hegney D, et al. How is medication prescribing ceased? A systematic review. Med Care 2011;49:24-36.